Research ArticleOriginal Article
Open Access

Prevalence of anosmia among COVID-19 patients in Taif City, Kingdom of Saudi Arabia

Adnan A. Mubaraki, Ghaida T. Alrbaiai, Afnan K. Sibyani, Rahaf M. Alhulayfi, Reema S. Alzaidi and Haneen S. Almalki
Saudi Medical Journal January 2021, 42 (1) 38-43; DOI: https://doi.org/10.15537/smj.2021.1.25588

References

  1. ↵
    1. Guan WJ,
    2. Ni ZY,
    3. Hu Y,
    4. Liang WH,
    5. Ou CQ,
    6. He JX,
    7. et al.
    (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382:1708–1720.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Ramanathan K,
    2. Antognini D,
    3. Combes A,
    4. Paden M,
    5. Zakhary B,
    6. Ogino M,
    7. et al.
    (2020) Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases. Lancet Respir Med 8:518–526.
    OpenUrl
  3. ↵
    1. Li Q,
    2. Guan X,
    3. Wu P,
    4. Wang X,
    5. Zhou L,
    6. Tong Y,
    7. et al.
    (2020) Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 382:1199–1207.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Wu Z,
    2. McGoogan JM
    (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China:summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA 323:1239–1242.
    OpenUrlCrossRefPubMed
  5. ↵
    1. World Health Organization
    Coronavirus disease (COVID-19) pandemic [Internet], [Updated 2019;Accessed 2020 June 22], Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
  6. ↵
    1. Lee Y,
    2. Min P,
    3. Lee S,
    4. Kim SW
    (2020) Prevalence and duration of acute loss of smell or taste in COVID-19 patients. J Korean Med Sci 35:e174.
    OpenUrlCrossRefPubMed
    1. Chen N,
    2. Zhou M,
    3. Dong X,
    4. Qu J,
    5. Gong F,
    6. Han Y,
    7. et al.
    (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China:a descriptive study. Lancet 395:507–513.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Hui DS,
    2. I Azhar E,
    3. Madani TA,
    4. Ntoumi F,
    5. Kock R,
    6. Dar O,
    7. et al.
    (2020) The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 91:264–266.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Vaira LA,
    2. Salzano G,
    3. Deiana G,
    4. De Riu G
    (2020) In response to anosmia and ageusia:common findings in COVID-19 patients. Laryngoscope 130:E695.
    OpenUrl
  10. ↵
    1. Gane SB,
    2. Kelly C,
    3. Hopkins C
    (2020) Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome? Rhinology 58:299–301.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Eccles R
    (2005) Understanding the symptoms of the common cold and influenza. Lancet Infect Dis 5:718–725.
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    1. Dubé M,
    2. Le Coupanec A,
    3. Wong AHM,
    4. Rini JM,
    5. Desforges M,
    6. Talbot PJ
    (2018) Axonal transport enables neuron-to-neuron propagation of human coronavirus OC43. J Virol 92:e00404–e00418.
    OpenUrl
  13. ↵
    1. Kaye R,
    2. Chang CWD,
    3. Kazahaya K,
    4. Brereton J,
    5. Denneny JC III.
    (2020) COVID-19 anosmia reporting tool:initial findings. Otolaryngol Head Neck Surg 163:132–134.
    OpenUrl
  14. ↵
    1. Hopkins C,
    2. Kumar N
    ENT UK;2020 [Please cite date accessed], Loss of sense of smell as marker of COVID-19 infection [Internet]. Available from: https://www.entuk.org/sites/default/files/files/Loss%20of%20sense%20of%20smell%20as%20marker%20of%20COVID.pdf.
  15. ↵
    1. Niazkar HR,
    2. Zibaee B,
    3. Nasimi A,
    4. Bahri N
    (2020) The neurological manifestations of COVID-19:a review article. Neurol Sci 41:1667–1671.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Lechien JR,
    2. Chiesa-Estomba CM,
    3. De Siati DR,
    4. Horoi M,
    5. Le Bon SD,
    6. Rodriguez A,
    7. et al.
    (2020) Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19):a multicenter European study. Eur Arch Otorhinolaryngol 277:2251–2261.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Patel A,
    2. Charani E,
    3. Ariyanayagam D,
    4. Abdulaal A,
    5. Denny SJ,
    6. Mughal N,
    7. et al.
    (2020) New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection. Clin Microbiol Infect 26:1236–1241.
    OpenUrl
  18. ↵
    1. Yan CH,
    2. Faraji F,
    3. Prajapati DP,
    4. Boone CE,
    5. DeConde AS
    (2020) Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol 10:806–813.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Klopfenstein T,
    2. Kadiane-Oussou NJ,
    3. Toko L,
    4. Royer PY,
    5. Lepiller Q,
    6. Gendrin V,
    7. et al.
    (2020) Features of anosmia in COVID-19. Med Mal Infect 50:436–439.
    OpenUrl
  20. ↵
    1. Luers JC,
    2. Rokohl AC,
    3. Loreck N,
    4. Wawer Matos PA,
    5. Augustin M,
    6. Dewald F,
    7. et al.
    (2020) Olfactory and gustatory dysfunction in coronavirus disease 2019 (COVID-19). Clin Infect Dis 71:2262–2264.
    OpenUrl
  21. ↵
    1. Hummel T,
    2. Heilmann S,
    3. Landis BN,
    4. et al.
    (2006) Perceptual differences between chemical stimuli presented through the ortho- or retronasal route. Flavour and fragrance journal 21:42–47.
    OpenUrl
  22. ↵
    1. Paderno A,
    2. Schreiber A,
    3. Grammatica A,
    4. Raffetti E,
    5. Tomasoni M,
    6. Gualtieri T,
    7. et al.
    (2020) Smell and taste alterations in COVID-19:a cross-sectional analysis of different cohorts. Int Forum Allergy Rhinol 10:955–962.
    OpenUrl
  23. ↵
    1. Speth MM,
    2. Singer-Cornelius T,
    3. Oberle M,
    4. Gengler I,
    5. Brockmeier SJ,
    6. Sedaghat AR
    (2020) Olfactory dysfunction and sinonasal symptomatology in COVID-19:prevalence severity, timing, and associated characteristics. Otolaryngol Head Neck Surg 163:114–120.
    OpenUrlCrossRefPubMed
  24. ↵
    1. Zubair AS,
    2. McAlpine LS,
    3. Gardin T,
    4. Farhadian S,
    5. Kuruvilla DE,
    6. Spudich S
    (2020) Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019:a review. JAMA Neurol 77:1018–1027.
    OpenUrl
  25. ↵
    1. Asadi-Pooya AA,
    2. Simani L
    (2020) Central nervous system manifestations of COVID-19:a systematic review. J Neurol Sci 413:116832.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords